{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:27:01Z","timestamp":1770391621546,"version":"3.49.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,5]]},"DOI":"10.7759\/cureus.103067","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:48:12Z","timestamp":1770353292000},"source":"Crossref","is-referenced-by-count":0,"title":["The Role of Complement Component C5a in the Pathogenesis of Diabetic Kidney Disease: A New Kid on the Block?"],"prefix":"10.7759","author":[{"given":"Virginia","family":"Geladari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achilleas","family":"Betsikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Pallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Sabanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2021.0125","article-title":"The complement pathway: new insights into immunometabolic signaling in diabetic kidney disease","volume":"37","author":"Tan SM","year":"2022","unstructured":"Tan SM, Snelson M, \u00d8stergaard JA, Coughlan MT. The complement pathway: new insights into immunometabolic signaling in diabetic kidney disease. Antioxid Redox Signal. 2022, 37:781-801. 10.1089\/ars.2021.0125","journal-title":"Antioxid Redox Signal"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.07.031","article-title":"Role of complement in diabetes","volume":"114","author":"Ajjan RA","year":"2019","unstructured":"Ajjan RA, Schroeder V. Role of complement in diabetes. Mol Immunol. 2019, 114:270-7. 10.1016\/j.molimm.2019.07.031","journal-title":"Mol Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.31","article-title":"The role of the complement system in diabetic nephropathy","volume":"13","author":"Flyvbjerg A","year":"2017","unstructured":"Flyvbjerg A. The role of the complement system in diabetic nephropathy. Nat Rev Nephrol. 2017, 13:311-8. 10.1038\/nrneph.2017.31","journal-title":"Nat Rev Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho NH","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, et al.. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018, 138:271-81. 10.1016\/j.diabres.2018.02.023","journal-title":"Diabetes Res Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/kidneydial2030038","article-title":"The epidemiology of diabetic kidney disease","volume":"2","author":"Hoogeveen EK","year":"2022","unstructured":"Hoogeveen EK. The epidemiology of diabetic kidney disease. Kidney Dial. 2022, 2:433-42. 10.3390\/kidneydial2030038","journal-title":"Kidney Dial"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0085","article-title":"Economic costs of diabetes in the US in 2022","volume":"47","author":"Parker ED","year":"2024","unstructured":"Parker ED, Lin J, Mahoney T, et al.. Economic costs of diabetes in the US in 2022. Diabetes Care. 2024, 47:26-43. 10.2337\/dci23-0085","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2024.100873","article-title":"Healthcare costs across diabetic kidney disease stages: a veterans affairs study","volume":"6","author":"Kim K","year":"2024","unstructured":"Kim K, Crook J, Lu CC, et al.. Healthcare costs across diabetic kidney disease stages: a veterans affairs study. Kidney Med. 2024, 6:100873. 10.1016\/j.xkme.2024.100873","journal-title":"Kidney Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.33590\/emjnephrol\/22-00060","article-title":"Pathophysiology of diabetic kidney disease","volume":"10","author":"Qazi M","year":"2022","unstructured":"Qazi M, Sawaf H, Ismail J, Qazi H, Vachharajani T. Pathophysiology of diabetic kidney disease. EMJ Nephrol. 2022, 10:102-13. 10.33590\/emjnephrol\/22-00060","journal-title":"EMJ Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1143-4","article-title":"The interconnection between immuno-metabolism, diabetes, and CKD","volume":"19","author":"Bonacina F","year":"2019","unstructured":"Bonacina F, Baragetti A, Catapano AL, Norata GD. The interconnection between immuno-metabolism, diabetes, and CKD. Curr Diab Rep. 2019, 19:21. 10.1007\/s11892-019-1143-4","journal-title":"Curr Diab Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2013.05.002","article-title":"Diabetic kidney disease and immune modulation","volume":"13","author":"Hickey FB","year":"2013","unstructured":"Hickey FB, Martin F. Diabetic kidney disease and immune modulation. Curr Opin Pharmacol. 2013, 13:602-12. 10.1016\/j.coph.2013.05.002","journal-title":"Curr Opin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2019.10.003","article-title":"Complement and the kidney: an overview","volume":"27","author":"Thurman JM","year":"2020","unstructured":"Thurman JM. Complement and the kidney: an overview. Adv Chronic Kidney Dis. 2020, 27:86-94. 10.1053\/j.ackd.2019.10.003","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment","volume":"28","author":"Tonneijck L","year":"2017","unstructured":"Tonneijck L, Muskiet MH, Smits MM, et al.. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol. 2017, 28:1023-39. 10.1681\/ASN.2016060666","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8020040","article-title":"Targeting redox imbalance as an approach for diabetic kidney disease","volume":"8","author":"Matoba K","year":"2020","unstructured":"Matoba K, Takeda Y, Nagai Y, et al.. Targeting redox imbalance as an approach for diabetic kidney disease. Biomedicines. 2020, 8:40. 10.3390\/biomedicines8020040","journal-title":"Biomedicines"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.205","article-title":"Characterization of glomerular diseases using proteomic analysis of laser capture microdissected glomeruli","volume":"25","author":"Satoskar AA","year":"2012","unstructured":"Satoskar AA, Shapiro JP, Bott CN, et al.. Characterization of glomerular diseases using proteomic analysis of laser capture microdissected glomeruli. Mod Pathol. 2012, 25:709-21. 10.1038\/modpathol.2011.205","journal-title":"Mod Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62101-5","article-title":"Urinary Complement proteome strongly linked to diabetic kidney disease progression","volume":"16","author":"Md Dom ZI","year":"2025","unstructured":"Md Dom ZI, Moon S, Satake E, et al.. Urinary Complement proteome strongly linked to diabetic kidney disease progression. Nat Commun. 2025, 16:7291. 10.1038\/s41467-025-62101-5","journal-title":"Nat Commun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2025.04.061","article-title":"Complement proteins identify rapidly progressive diabetic kidney disease","volume":"10","author":"Yun D","year":"2025","unstructured":"Yun D, Bae S, Gao Y, et al.. Complement proteins identify rapidly progressive diabetic kidney disease. Kidney Int Rep. 2025, 10:2296-310. 10.1016\/j.ekir.2025.04.061","journal-title":"Kidney Int Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0043","article-title":"Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agility","volume":"69","author":"Tan SM","year":"2020","unstructured":"Tan SM, Ziemann M, Thallas-Bonke V, et al.. Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agility. Diabetes. 2020, 69:83-98. 10.2337\/db19-0043","journal-title":"Diabetes"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108758","article-title":"Therapeutic potential of targeting complement C5a receptors in diabetic kidney disease","volume":"24","author":"Trambas IA","year":"2023","unstructured":"Trambas IA, Coughlan MT, Tan SM. Therapeutic potential of targeting complement C5a receptors in diabetic kidney disease. Int J Mol Sci. 2023, 24:8758. 10.3390\/ijms24108758","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115835","article-title":"Role of C5a in inflammatory responses","volume":"23","author":"Guo RF","year":"2005","unstructured":"Guo RF, Ward PA. Role of C5a in inflammatory responses. Annu Rev Immunol. 2005, 23:821-52. 10.1146\/annurev.immunol.23.021704.115835","journal-title":"Annu Rev Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1038073","article-title":"Cellular phenotypic transitions in diabetic nephropathy: an update","volume":"13","author":"Cao Y","year":"2022","unstructured":"Cao Y, Lin JH, Hammes HP, Zhang C. Cellular phenotypic transitions in diabetic nephropathy: an update. Front Pharmacol. 2022, 13:1038073. 10.3389\/fphar.2022.1038073","journal-title":"Front Pharmacol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S457526","article-title":"The role of immune cells in DKD: mechanisms and targeted therapies","volume":"17","author":"Peng QY","year":"2024","unstructured":"Peng QY, An Y, Jiang ZZ, Xu Y. The role of immune cells in DKD: mechanisms and targeted therapies. J Inflamm Res. 2024, 17:2103-18. 10.2147\/JIR.S457526","journal-title":"J Inflamm Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102209","article-title":"Fiery connections: macrophage-mediated inflammation, the journey from obesity to type 2 diabetes mellitus and diabetic kidney disease","volume":"12","author":"Sinha SK","year":"2024","unstructured":"Sinha SK, Carpio MB, Nicholas SB. Fiery connections: macrophage-mediated inflammation, the journey from obesity to type 2 diabetes mellitus and diabetic kidney disease. Biomedicines. 2024, 12:2209. 10.3390\/biomedicines12102209","journal-title":"Biomedicines"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2561232","article-title":"Progress in the study of the role of C5a-induced tubular cell senescence in the progression of diabetic kidney disease","volume":"57","author":"Guo C","year":"2025","unstructured":"Guo C, Li X, Fan Z, et al.. Progress in the study of the role of C5a-induced tubular cell senescence in the progression of diabetic kidney disease. Ann Med. 2025, 57:2561232. 10.1080\/07853890.2025.2561232","journal-title":"Ann Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S543814","article-title":"The role of renal cell senescence in diabetic kidney disease: mechanisms and therapeutic advances","volume":"18","author":"Yan Z","year":"2025","unstructured":"Yan Z, Xu J, Liu T, et al.. The role of renal cell senescence in diabetic kidney disease: mechanisms and therapeutic advances. Diabetes Metab Syndr Obes. 2025, 18:3323-41. 10.2147\/DMSO.S543814","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16157","article-title":"Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis","volume":"25","author":"Li L","year":"2021","unstructured":"Li L, Wei T, Liu S, et al.. Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis. J Cell Mol Med. 2021, 25:960-74. 10.1111\/jcmm.16157","journal-title":"J Cell Mol Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110081","article-title":"Corrigendum to \u201cThe anaphylatoxin C5a: structure, function, signaling, physiology, disease, and therapeutics\u201d","volume":"118","author":"Ghosh M","year":"2023","unstructured":"Ghosh M, Rana S. Corrigendum to \u201cThe anaphylatoxin C5a: structure, function, signaling, physiology, disease, and therapeutics\u201d. Int Immunopharmacol. 2023, 118:110089. 10.1016\/j.intimp.2023.110081","journal-title":"Int Immunopharmacol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2174\/156652412802480925","article-title":"Structure, function and control of complement C5 and its proteolytic fragments","volume":"12","author":"Laursen NS","year":"2012","unstructured":"Laursen NS, Magnani F, Gottfredsen RH, et al.. Structure, function and control of complement C5 and its proteolytic fragments. Curr Mol Med. 2012, 12:1083-97. 10.2174\/156652412802480925","journal-title":"Curr Mol Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2018.05.018","article-title":"Properdin: a multifaceted molecule involved in inflammation and diseases","volume":"102","author":"Chen JY","year":"2018","unstructured":"Chen JY, Cortes C, Ferreira VP. Properdin: a multifaceted molecule involved in inflammation and diseases. Mol Immunol. 2018, 102:58-72. 10.1016\/j.molimm.2018.05.018","journal-title":"Mol Immunol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.icb.7100166","article-title":"Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2","volume":"86","author":"Lee H","year":"2008","unstructured":"Lee H, Whitfeld PL, Mackay CR. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2. Immunol Cell Biol. 2008, 86:153-60. 10.1038\/sj.icb.7100166","journal-title":"Immunol Cell Biol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24851-w","article-title":"Valproic acid attenuates cellular senescence in diabetic kidney disease through the inhibition of complement C5a receptors","volume":"12","author":"Coughlan MT","year":"2022","unstructured":"Coughlan MT, Ziemann M, Laskowski A, et al.. Valproic acid attenuates cellular senescence in diabetic kidney disease through the inhibition of complement C5a receptors. Sci Rep. 2022, 12:20278. 10.1038\/s41598-022-24851-w","journal-title":"Sci Rep"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00780.x","article-title":"Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization","volume":"60","author":"Abe K","year":"2001","unstructured":"Abe K, Miyazaki M, Koji T, et al.. Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization. Kidney Int. 2001, 60:137-46. 10.1046\/j.1523-1755.2001.00780.x","journal-title":"Kidney Int"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.7.3883","article-title":"Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils","volume":"170","author":"De Vries B","year":"2003","unstructured":"De Vries B, Ko\u0308hl J, Leclercq WK, et al.. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol. 2003, 170:3883-9. 10.4049\/jimmunol.170.7.3883","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8193932","article-title":"The controversial C5a receptor C5aR2: its role in health and disease","volume":"2017","author":"Zhang T","year":"2017","unstructured":"Zhang T, Garstka MA, Li K. The controversial C5a receptor C5aR2: its role in health and disease. J Immunol Res. 2017, 2017:8193932. 10.1155\/2017\/8193932","journal-title":"J Immunol Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2025.153059","article-title":"Complement C5a receptor 2 attenuates diabetic kidney disease by promoting mitochondria-associated endoplasmic reticulum membrane formation mediated by PSS-MFN2 interaction","volume":"230","author":"Zhao Y","year":"2025","unstructured":"Zhao Y, Chen M. Complement C5a receptor 2 attenuates diabetic kidney disease by promoting mitochondria-associated endoplasmic reticulum membrane formation mediated by PSS-MFN2 interaction. Immunobiology. 2025, 230:153059. 10.1016\/j.imbio.2025.153059","journal-title":"Immunobiology"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2025.153007","article-title":"The enigmatic role of C5aR2 in diabetic kidney disease","volume":"230","author":"Trambas I","year":"2025","unstructured":"Trambas I, Laskowski A, Khayyira A, et al.. The enigmatic role of C5aR2 in diabetic kidney disease. Immunobiology. 2025, 230:153007. 10.1016\/j.imbio.2025.153007","journal-title":"Immunobiology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.006508","article-title":"The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages","volume":"24","author":"Yu S","year":"2019","unstructured":"Yu S, Wang D, Huang L, et al.. The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages. J Biol Chem. 2019, 24:8384-94. 10.1074\/jbc.RA118.006508","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1042\/CS20160636","article-title":"Diabetic nephropathy-is this an immune disorder?","volume":"131","author":"Tesch GH","year":"2017","unstructured":"Tesch GH. Diabetic nephropathy-is this an immune disorder?. Clin Sci. 2017, 131:2183-99. 10.1042\/CS20160636","journal-title":"Clin Sci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.958790","article-title":"Immune responses in diabetic nephropathy: pathogenic mechanisms and therapeutic target","volume":"13","author":"Chen J","year":"2022","unstructured":"Chen J, Liu Q, He J, et al.. Immune responses in diabetic nephropathy: pathogenic mechanisms and therapeutic target. Front Immunol. 2022, 13:958790. 10.3389\/fimmu.2022.958790","journal-title":"Front Immunol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00314.2016","article-title":"Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets","volume":"312","author":"Pichler R","year":"2017","unstructured":"Pichler R, Afkarian M, Dieter BP, Tuttle KR. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets. Am J Physiol Renal Physiol. 2017, 312:F716-31. 10.1152\/ajprenal.00314.2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1159\/000313363","article-title":"Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease","volume":"31","author":"Siragy HM","year":"2010","unstructured":"Siragy HM, Carey RM. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am J Nephrol. 2010, 31:541-50. 10.1159\/000313363","journal-title":"Am J Nephrol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.5897\/AJB11.2313","article-title":"Activation of the lectin complement pathway on human renal glomerular endothelial cells triggered by high glucose and mannose-binding lectin","volume":"10","author":"Fan WX","year":"2011","unstructured":"Fan WX, Huang SM, Liu F, et al.. Activation of the lectin complement pathway on human renal glomerular endothelial cells triggered by high glucose and mannose-binding lectin. Afr J Biotechnol. 2011, 10:18539-49. 10.5897\/AJB11.2313","journal-title":"Afr J Biotechnol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1079","article-title":"Binding of mannose-binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetes","volume":"26","author":"Fortpied J","year":"2010","unstructured":"Fortpied J, Vertommen D, Van Schaftingen E. Binding of mannose-binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetes. Diabetes Metab Res Rev. 2010, 26:254-60. 10.1002\/dmrr.1079","journal-title":"Diabetes Metab Res Rev"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14134588","article-title":"The relationship of the plasma glycated CD59 level with microvascular complications in diabetic patients and its evaluation as a predictive marker","volume":"28","author":"Yilmaz O","year":"2025","unstructured":"Yilmaz O, Erinc O, Gungordu AG, et al.. The relationship of the plasma glycated CD59 level with microvascular complications in diabetic patients and its evaluation as a predictive marker. J Clin Med. 2025, 28:4588. 10.3390\/jcm14134588","journal-title":"J Clin Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84900-4","article-title":"Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies","volume":"15","author":"Yang Y","year":"2025","unstructured":"Yang Y, Zhang Y, Li Y, et al.. Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies. Sci Rep. 2025, 15:495. 10.1038\/s41598-024-84900-4","journal-title":"Sci Rep"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.10.2653","article-title":"Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes","volume":"53","author":"Qin X","year":"2004","unstructured":"Qin X, Goldfine A, Krumrei N, et al.. Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes. Diabetes. 2004, 53:2653-61. 10.2337\/diabetes.53.10.2653","journal-title":"Diabetes"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1495","article-title":"Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy","volume":"58","author":"Kaunisto MA","year":"2009","unstructured":"Kaunisto MA, Sj\u00f6lind L, Sallinen R, et al.. Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy. Diabetes. 2009, 58:1710-4. 10.2337\/db08-1495","journal-title":"Diabetes"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3332-7","article-title":"Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18 year follow-up study","volume":"57","author":"\u00d8stergaard JA","year":"2014","unstructured":"\u00d8stergaard JA, Thiel S, Hovind P, et al.. Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18 year follow-up study. Diabetologia. 2014, 57:2201-7. 10.1007\/s00125-014-3332-7","journal-title":"Diabetologia"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2018.03.033","article-title":"Lectin-induced renal local complement activation is involved in tubular interstitial injury in diabetic nephropathy","volume":"482","author":"Zheng JM","year":"2018","unstructured":"Zheng JM, Ren XG, Jiang ZH, et al.. Lectin-induced renal local complement activation is involved in tubular interstitial injury in diabetic nephropathy. Clin Chim Acta. 2018, 482:65-73. 10.1016\/j.cca.2018.03.033","journal-title":"Clin Chim Acta"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13264","article-title":"C3c deposition predicts worse renal outcomes in patients with biopsy\u2010proven diabetic kidney disease in type 2 diabetes mellitus","volume":"14","author":"Li MR","year":"2022","unstructured":"Li MR, Sun ZJ, Chang DY, et al.. C3c deposition predicts worse renal outcomes in patients with biopsy\u2010proven diabetic kidney disease in type 2 diabetes mellitus. J Diabetes. 2022, 14:291-7. 10.1111\/1753-0407.13264","journal-title":"J Diabetes"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.2337\/db10-1181","article-title":"Transcriptome analysis of human diabetic kidney disease","volume":"60","author":"Woroniecka KI","year":"2011","unstructured":"Woroniecka KI, Park AS, Mohtat D, et al.. Transcriptome analysis of human diabetic kidney disease. Diabetes. 2011, 60:2354-69. 10.2337\/db10-1181","journal-title":"Diabetes"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/proteomes9040049","article-title":"Molecular mapping of urinary complement peptides in kidney diseases","volume":"9","author":"Wendt R","year":"2021","unstructured":"Wendt R, Siwy J, He T, et al.. Molecular mapping of urinary complement peptides in kidney diseases. Proteomes. 2021, 9:49. 10.3390\/proteomes9040049","journal-title":"Proteomes"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0851","article-title":"Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: a 12-year follow-up study","volume":"38","author":"\u00d8stergaard JA","year":"2015","unstructured":"\u00d8stergaard JA, Thiel S, Lajer M, et al.. Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: a 12-year follow-up study. Diabetes Care. 2015, 38:1898-903. 10.2337\/dc15-0851","journal-title":"Diabetes Care"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2018.04.001","article-title":"Complement activation in patients with diabetic nephropathy","volume":"45","author":"Li XQ","year":"2019","unstructured":"Li XQ, Chang DY, Chen M, Zhao MH. Complement activation in patients with diabetic nephropathy. Diabetes Metab. 2019, 45:248-53. 10.1016\/j.diabet.2018.04.001","journal-title":"Diabetes Metab"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2018.06.018","article-title":"Complement 7 is up-regulated in human early diabetic kidney disease","volume":"188","author":"Sircar M","year":"2018","unstructured":"Sircar M, Rosales IA, Selig MK, et al.. Complement 7 is up-regulated in human early diabetic kidney disease. Am J Pathol. 2018, 188:2147-54. 10.1016\/j.ajpath.2018.06.018","journal-title":"Am J Pathol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01596-3","article-title":"Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy","volume":"44","author":"Zhao L","year":"2021","unstructured":"Zhao L, Zhang Y, Liu F, et al.. Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. J Endocrinol Invest. 2021, 44:2709-23. 10.1007\/s40618-021-01596-3","journal-title":"J Endocrinol Invest"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2018.08.011","article-title":"Complement deposition on renal histopathology of patients with diabetic nephropathy","volume":"45","author":"Sun ZJ","year":"2019","unstructured":"Sun ZJ, Li XQ, Chang DY, et al.. Complement deposition on renal histopathology of patients with diabetic nephropathy. Diabetes Metab. 2019, 45:363-8. 10.1016\/j.diabet.2018.08.011","journal-title":"Diabetes Metab"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.01.039","article-title":"The C5a\/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia\/reperfusion injury","volume":"96","author":"Peng Q","year":"2019","unstructured":"Peng Q, Wu W, Wu KY, et al.. The C5a\/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia\/reperfusion injury. Kidney Int. 2019, 96:117-28. 10.1016\/j.kint.2019.01.039","journal-title":"Kidney Int"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.21608\/ejhm.2022.272498","article-title":"Urinary and tissue immunohistochemical expression of complement activation products among diabetic nephropathy patients in different stages","volume":"89","author":"Abdelwahab MM","year":"2022","unstructured":"Abdelwahab MM, Mohammed EM, Hussein S, et al.. Urinary and tissue immunohistochemical expression of complement activation products among diabetic nephropathy patients in different stages. Egypt J Hosp Med. 2022, 89:7009-18. 10.21608\/ejhm.2022.272498","journal-title":"Egypt J Hosp Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4146-5","article-title":"Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017)","volume":"19","author":"Ladhani SN","year":"2019","unstructured":"Ladhani SN, Campbell H, Lucidarme J, et al.. Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017). BMC Infect Dis. 2019, 19:522. 10.1186\/s12879-019-4146-5","journal-title":"BMC Infect Dis"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac189","article-title":"SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence","volume":"16","author":"Kalay Z","year":"2023","unstructured":"Kalay Z, Sahin OE, Copur S, et al.. SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence. Clin Kidney J. 2023, 16:52-60. 10.1093\/ckj\/sfac189","journal-title":"Clin Kidney J"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3390\/cells14050337","article-title":"Finerenone alleviates over-activation of complement C5a-C5aR1 axis of macrophages by regulating G protein subunit alpha i2 to improve diabetic nephropathy","volume":"14","author":"Li ZH","year":"2025","unstructured":"Li ZH, Sun ZJ, Tang SC, et al.. Finerenone alleviates over-activation of complement C5a-C5aR1 axis of macrophages by regulating G protein subunit alpha i2 to improve diabetic nephropathy . Cells. 2025, 14:337. 10.3390\/cells14050337","journal-title":"Cells"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437072-the-role-of-complement-component-c5a-in-the-pathogenesis-of-diabetic-kidney-disease-a-new-kid-on-the-block","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:48:13Z","timestamp":1770353293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437072-the-role-of-complement-component-c5a-in-the-pathogenesis-of-diabetic-kidney-disease-a-new-kid-on-the-block"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":61,"URL":"https:\/\/doi.org\/10.7759\/cureus.103067","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}